(Press-News.org) UPTON, NY—Scientists seeking ways to engineer the assembly of tiny particles measuring just billionths of a meter have achieved a new first—the formation of a single layer of nanoparticles on a liquid surface where the properties of the layer can be easily switched. Understanding the assembly of such nanostructured thin films could lead to the design of new kinds of filters or membranes with a variable mechanical response for a wide range of applications. In addition, because the scientists used tiny synthetic strands of DNA to hold the nanoparticles together, the study also offers insight into the mechanism of interactions of nanoparticles and DNA molecules near a lipid membrane. This understanding could inform the emerging use of nanoparticles as vehicles for delivering genes across cellular membranes.
"Our work reveals how DNA-coated nanoparticles interact and re-organize at a lipid interface, and how that process affects the properties of a "thin film" made of DNA-linked nanoparticles," said physicist Oleg Gang who led the study at the Center for Functional Nanomaterials (CFN, http://www.bnl.gov/cfn/) at the U.S. Department of Energy's Brookhaven National Laboratory. The results will be published in the June 11, 2014 print edition of the Journal of the American Chemical Society.
Like the molecule that carries genetic information in living things, the synthetic DNA strands used as "glue" to bind nanoparticles in this study have a natural tendency to pair up when the bases that make up the rungs of the twisted-ladder shaped molecule match up in a particular way. Scientists at Brookhaven have made great use of the specificity of this attractive force to get nanoparticles coated with single synthetic DNA strands to pair up and assemble in a variety of three-dimensional architectures. The goal of the present study was to see if the same approach could be used to achieve designs of two-dimensional, one-particle-thick films.
"Many of the applications we envision for nanoparticles, such as optical coatings and photovoltaic and magnetic storage devices, require planar geometry," said Sunita Srivastava, a Stony Brook University postdoctoral researcher and the lead author on the paper. Other groups of scientists have assembled such planes of nanoparticles, essentially floating them on a liquid surface, but these single-layer arrays have all been static, she explained. "Using DNA linker molecules gives us a way to control the interactions between the nanoparticles."
As described in the paper, the scientists demonstrated their ability to achieve differently structured monolayers, from a viscous fluid-like array to a more tightly woven cross-linked elastic mesh—and switch between those different states—by varying the strength of the pairing between complementary DNA strands and adjusting other variables, including the electrostatic charge on the liquid assembly surface and the concentration of salt.
When the surface they used, a lipid, has a strong positive charge it attracts the negatively charged DNA strands that coat the nanoparticles. That electrostatic attraction and the repulsion between the negatively charged DNA molecules surrounding adjacent nanoparticles overpower the attractive force between complementary DNA bases. As a result, the particles form a rather loosely arrayed free-floating viscous monolayer. Adding salt changes the interactions and overcomes the repulsion between like-charged DNA strands, allowing the base pairs to match up and link the nanoparticles together more closely, first forming string-like arrays, and with more salt, a more solid yet elastic mesh-like layer.
"The mechanism of this phase transition is not obvious," said Gang. "It cannot be understood from the repulsion-attraction interactions alone. With the help of theory, we reveal that there are collective effects of the flexible DNA chains that drive the system in the particular states. And it is only possible when the particle sizes and the DNA chain sizes are comparable—on the order of 20-50 nanometers," he said.
As part of the study, the scientists examined the different configurations of the nanoparticles on top of the liquid layer using x-ray scattering at Brookhaven's National Synchrotron Light Source (NSLS, http://www.bnl.gov/ps/nsls/about-NSLS.asp). They also transferred the monolayer produced at each salt concentration to a solid surface so they could visualize it using electron microscopy at the CFN.
"Creating these particle monolayers at a liquid interface is very convenient and effective because the particles' two-dimensional structure is very 'fluid' and can be easily manipulated—unlike on a solid substrate, where the particles can easily get stuck to the surface," Gang said. "But in some applications, we may need to transfer the assembled layer to such a solid surface. By combining the synchrotron scattering and electron microscopy imaging we could confirm that the transfer can be done with minimal disruption to the monolayer."
The switchable nature of the monolayers might be particularly attractive for applications such as membranes used for purification and separations, or to control the transport of molecular or nano-scale objects through liquid interfaces. For example, said Gang, when particles are linked but move freely at the interface, they may allow an object—a molecule—to pass through the interface. "However, when we induce linkages between particles to form a mesh-like network, any object larger than the mesh-size of the network cannot penetrate through this very thin film. "
"In principle, we can even think about such on-demand regulated networks to adjust the mesh size dynamically. Because, of the nanoscale size-regime, we might envision using such membranes for filtering proteins or other nanoparticles," he said.
Understanding how synthetic DNA-coated nanoparticles interact with a lipid surface may also offer insight into how such particles coated with actual genes might interact with cell membranes—which are largely composed of lipids—and with one another in a lipid environment.
"Other groups have considered using DNA-coated nanoparticles to detect genes within cells, or even for delivering genes to cells for gene therapy and such approaches," said Gang. "Our study is the first of its kind to look at the structural aspects of DNA-particle/lipid interface directly using x-ray scattering. I believe this approach has significant value as a platform for more detailed investigations of realistic systems important for these new biomedical applications of DNA-nanoparticle pairings," Gang said.
INFORMATION:
This research was sponsored by the DOE Office of Science (BES).
DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov.
The Center for Functional Nanomaterials at Brookhaven National Laboratory is one of the five DOE Nanoscale Science Research Centers (NSRCs), premier national user facilities for interdisciplinary research at the nanoscale. Together the NSRCs comprise a suite of complementary facilities that provide researchers with state-of-the-art capabilities to fabricate, process, characterize and model nanoscale materials, and constitute the largest infrastructure investment of the National Nanotechnology Initiative. The NSRCs are located at DOE's Argonne, Brookhaven, Lawrence Berkeley, Oak Ridge and Sandia and Los Alamos national laboratories. For more information about the DOE NSRCs, please visit http://nano.energy.gov.
One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE's Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit applied science and technology organization.
Related Links
Scientific paper: "Two-Dimensional DNA-Programmable Assembly of Nanoparticles at Liquid Interfaces" END
DNA-linked nanoparticles form switchable 'thin films' on a liquid surface
Possible pathway to adjustable filters, surfaces with variable mechanical response, or even new ways to deliver genes for biomedical applications
2014-06-11
ELSE PRESS RELEASES FROM THIS DATE:
Scientists unravel the genetic secrets of nature's master of mimicry
2014-06-11
Scientists investigating how one of the greatest shape shifters in the natural world is able to trick predators to avoid being eaten have identified the gene behind the fascinating feat.
The African Swallowtail butterfly, also known as the 'Mocker Swallowtail' or the 'Flying Handkerchief,' can appear to change both colour and shape.
Males of the species fly boldly around the tree tops, their rapid flight making them look like shaking handkerchiefs, however females lurk in the bushes and pretend to be examples of Monarch butterflies that are nasty to eat.
The females ...
Infant nutrition and development of type 1 diabetes
2014-06-11
Previous studies have indicated that early exposure to complex foreign proteins, such as cow's milk proteins, increases the risk of type 1 diabetes in predisposed individuals.
"Therefore, In 2002, we embarked on a large-scale study on more than 2100 infants with a family member affected by type 1 diabetes and with genetic disease susceptibility to find an answer to the question whether delaying the exposure to complex foreign proteins will decrease the risk of diabetes", tells Professor Mikael Knip from the University of Helsinki, the leader of the TRIGR Study.
After ...
New guidance on how and when to stop immunosuppressants in lupus patients
2014-06-11
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that, for the majority of lupus patients who are in remission, it is possible to successfully stop immunosuppressant therapy without triggering a flare of their disease.1 Within two years, it was possible to stop the immunosuppressant in about 70% of clinically stable patients. Half were successful within three years, and this proportion remained stable for up to five years.1
Lupus is a chronic inflammatory disease that can affect any organ system, but mainly involves ...
First biomarkers found to predict severe osteoarthritis
2014-06-11
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) identify a correlation between the presence of biomarkers in the blood, known as micro RNAs (miRNAs), and the development of severe osteoarthritis (OA) of the knee or hip joint. The findings suggest that miRNAs may be used as biomarkers to predict severe OA disease in individuals.2
Preventative measures and early treatments are considered to be the most effective way of managing OA, but to date there has been no way of identifying the disease early on.2
"These ...
New data clarify relationship between diet and disease activity
2014-06-11
Two new studies presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) have helped clarify the relationship between the dietary intake of monounsaturated fatty acids and cholesterol with disease activity in rheumatoid arthritis (RA) and osteoarthritis (OA) respectively.
In the TOMORROW study, daily intake of monounsaturated fatty acids as a component of the Mediterranean diet has been shown to be an independent predictor of remission in patients with RA; monounsaturated fatty acids might therefore be suppressing disease activity1
In another ...
One-third of psoriatic arthritis patients are not receiving optimal dosing of adalimumab
2014-06-11
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit.1 Further data revealed that, in the case of the TNFα inhibitor infliximab, nearly three-quarters of PsA patients were on doses lower than recommended in international guidelines. 2
In the first study, after 28 weeks of treatment one-third of PsA patients were ...
Romosozumab signif increases bone mineral density and bone content compared with teriparatide
2014-06-11
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) shows that in postmenopausal women with low bone mass, romosozumab significantly increased bone mineral density and bone content in both the spine and hip compared to baseline, and also compared with the commonly prescribed anabolic agent teriparatide and placebo.1
Romosozumab, administered subcutaneously at monthly intervals over a period of 12 months, resulted in gains in both the trabecular* and cortical† compartments of the spine and hip regions, with important differences ...
Biosimilar CT-P13 matches infliximab in improving ankylosing spondylitis disease activity
2014-06-11
New data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) show that the newly-approved infliximab biosimilar CT-P13 achieves statistically similar improvements in disease activity, disability and mobility in patients with Ankylosing Spondylitis (AS) compared to its original reference product infliximab (INX).1
CT-P13 is the world's first biosimilar monoclonal antibody to receive a positive opinion from an advanced and developed nations' regulatory body. According to Dr Won Park, Inha University Hospital, Korea, and lead investigator ...
New patient empowerment and educational initiatives unveiled at EULAR 2014
2014-06-11
Five different presentations at the European League Against Rheumatism Annual Congress (EULAR 2014) have introduced new patient empowerment and educational initiatives, which are predicted to bring significant benefits to the many thousands of patients worldwide who suffer from a rheumatic disease.
These initiatives include:
A new model of patient care involving self-monitoring and patient initiated follow-up1
An online learning resource to prepare patients and carers to actively engage in research, guideline development, advocacy and media activities2
A new patient ...
EULAR driving research and innovation in rheumatic and RMDs in Europe
2014-06-11
The European League Against Rheumatism (EULAR) has announced today at its Annual Congress major successes in driving the public agenda for addressing the escalating burden of RMDs in Europe. These advances include:
Recognition for Rheumatic and Musculoskeletal Diseases (RMDs) from major European Commission research initiative, Horizon 2020
'FOREUM', Foundation for Research in Rheumatology, grants research funding for four osteoarthritis projects in its first year.
"It is with great satisfaction that we have seen a progressive dedication of EU research funds for RMDs ...
LAST 30 PRESS RELEASES:
The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski
Excessive screen time linked to early puberty and accelerated bone growth
First nationwide study discovers link between delayed puberty in boys and increased hospital visits
Traditional Mayan practices have long promoted unique levels of family harmony. But what effect is globalization having?
New microfluidic device reveals how the shape of a tumour can predict a cancer’s aggressiveness
Speech Accessibility Project partners with The Matthew Foundation, Massachusetts Down Syndrome Congress
Mass General Brigham researchers find too much sitting hurts the heart
New study shows how salmonella tricks gut defenses to cause infection
Study challenges assumptions about how tuberculosis bacteria grow
NASA Goddard Lidar team receives Center Innovation Award for Advancements
Can AI improve plant-based meats?
How microbes create the most toxic form of mercury
‘Walk this Way’: FSU researchers’ model explains how ants create trails to multiple food sources
A new CNIC study describes a mechanism whereby cells respond to mechanical signals from their surroundings
Study uncovers earliest evidence of humans using fire to shape the landscape of Tasmania
Researchers uncover Achilles heel of antibiotic-resistant bacteria
Scientists uncover earliest evidence of fire use to manage Tasmanian landscape
Interpreting population mean treatment effects in the Kansas City Cardiomyopathy Questionnaire
Targeting carbohydrate metabolism in colorectal cancer: Synergy of therapies
Stress makes mice’s memories less specific
Research finds no significant negative impact of repealing a Depression-era law allowing companies to pay workers with disabilities below minimum wage
Resilience index needed to keep us within planet’s ‘safe operating space’
How stress is fundamentally changing our memories
Time in nature benefits children with mental health difficulties: study
In vitro model enables study of age-specific responses to COVID mRNA vaccines
Sitting too long can harm heart health, even for active people
International cancer organizations present collaborative work during oncology event in China
One or many? Exploring the population groups of the largest animal on Earth
ETRI-F&U Credit Information Co., Ltd., opens a new path for AI-based professional consultation
New evidence links gut microbiome to chronic disease outcomes
[Press-News.org] DNA-linked nanoparticles form switchable 'thin films' on a liquid surfacePossible pathway to adjustable filters, surfaces with variable mechanical response, or even new ways to deliver genes for biomedical applications